title: The angiotensin II receptor type 2 agonist CGP 42112A stimulates NO production in the porcine jejunal mucosa.
abstract: BACKGROUND
  This study was conducted to elucidate if nitric oxide is released by the porcine jejunal mucosa upon selective stimulation of AT2 receptors and the possible involvement of iNOS, and to investigate the presence of jejunal AT1 and AT2 receptors. Young landrace pigs were anaesthetized with ketamine and alpha-chloralose. Jejunal luminal NO output was assessed by intraluminal tonometry and analysed by chemiluminescense. Western blot analysis quantified mucosal iNOS and detected AT1 and AT2 receptor protein expression. AT1 and AT2 receptor RNA expression was detected by rtPCR.
  
  
  RESULTS
  Baseline luminal NO output correlated significantly to baseline mucosal iNOS-protein content. In animals treated with the AT2-receptor agonist CGP42112A (n = 11) luminal NO output increased significantly (at 0.1 micrograms kg(-1) min(-1) and 1.0 micrograms kg(-1) min(-1)), but not in animals simultaneously treated with the AT2-receptor antagonist PD123319 (bolus 0.3 mgkg-1, infusion 0.03 mg kg(-1) h(-1)) (n = 7). No differences in iNOS protein expression were found between groups or before/after the administration of drugs. Western blot and rtPCR recognised expression of the AT1 and AT2 receptors in jejunal tissue.
  
  
  CONCLUSIONS
  The results suggest that activation of AT2 receptors increases jejunal luminal NO output. This response was not due to an increase in the expression of the iNOS protein in the mucosa.
authors.affiliation: Department of Gastrosurgical Research, Sahlgrenska Academy, Goteborg University, Sweden. sara.ewert@gastro.gu.se
authors.forename: Sara
authors.initials: S
authors.lastname: Ewert
authors.forename: Mats
authors.initials: M
authors.lastname: Laesser
authors.forename: Bernalt
authors.initials: B
authors.lastname: Johansson
authors.forename: Mathias
authors.initials: M
authors.lastname: Holm
authors.forename: Anders
authors.initials: A
authors.lastname: Aneman
authors.forename: Lars
authors.initials: L
authors.lastname: Fandriks
mesh_terms: D000818:Animals; D005260:Female; D015870:Gene Expression / Q000187:drug effects; D006439:Hemodynamics / Q000187:drug effects; D007413:Intestinal Mucosa / Q000187:drug effects* / Q000378:metabolism; D007583:Jejunum / Q000166:cytology*; D008297:Male; D009569:Nitric Oxide / Q000378:metabolism*; D019001:Nitric Oxide Synthase / Q000378:metabolism; D052247:Nitric Oxide Synthase Type II; D009842:Oligopeptides / Q000494:pharmacology*; D044140:Receptor, Angiotensin, Type 1 / Q000378:metabolism; D011945:Receptors, Angiotensin / Q000819:agonists*; D013552:Swine
chemical_list: D009842:Oligopeptides; D044140:Receptor, Angiotensin, Type 1; D011945:Receptors, Angiotensin; C060894:CGP 42112A; D009569:Nitric Oxide; D019001:Nitric Oxide Synthase; D052247:Nitric Oxide Synthase Type II